physician perceptions of testing practices in patients with egfr mutated nsclc
Published 2 years ago • 68 plays • Length 1:41Download video MP4
Download video MP3
Similar videos
-
58:24
time for even more precision in testing and treatment of egfr-mutated nsclc
-
9:30
egfr testing for nsclc
-
2:55
limitations of genetic testing for actionable mutations in lung cancer
-
1:05
advances in managing krasg12c- and egfr-mutated nsclc
-
1:52
patritumab deruxtecan in patients with egfr-mutant nsclc
-
8:25
egfr & alk/ros1 testing in squamous nsclc
-
7:46
egfr and pd-l1 testing in locally advanced nsclc
-
2:10
dr. pennell on importance of egfr testing in nsclc
-
5:00
case 2: testing for egfr in lung adenocarcinoma
-
5:07
how is molecular testing used to select upfront therapy in patients with egfr mutations?
-
9:27
post-hoc analysis of sequential afatinib and osimertinib in nsclc patients
-
1:41
dr. husain on monitoring the emergence of t790m in lung cancer
-
12:23
clinical clips: spotlighting hot topics in nsclc harboring egfr mutations
-
7:41
repeat testing at progression of egfr nsclc
-
1:15
molecular testing recommendations for nsclc
-
5:37
treatment patterns in patients with egfr positive lung cancer: a real world patient report
-
0:29
can you pass the healthy lung test? dr. mandell #shorts
-
3:00
what are lung function tests?
-
1:51:28
updates in the management of egfrm nsclc